Trial Profile
An early phase 2 study of NST-141 in patients with atopic dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs NST 141 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Nippon Shinyaku; Taiho Pharmaceutical
- 20 Jan 2016 New trial record